Comparison of analytical platforms for cerebrospinal fluid measures of Aβ(1-42), total tau and p-tau(181) for identifying Alzheimer’s disease amyloid plaque pathology

OBJECTIVE: Cerebrospinal fluid (CSF) biomarkers of Alzheimer’s disease (AD) are currently being considered for inclusion in revised diagnostic criteria for research and/or clinical purposes to increase the certainty of ante-mortem diagnosis. Establishing biomarker validity requires demonstration tha...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Fagan, Anne M., Shaw, Leslie M., Xiong, Chengjie, Vanderstichele, Hugo, Mintun, Mark A., Trojanowski, John Q., Coart, Els, Morris, John C., Holtzman, David M.
Format: Artigo
Langue:Inglês
Publié: 2011
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3154969/
https://ncbi.nlm.nih.gov/pubmed/21555603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/archneurol.2011.105
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires